Literature DB >> 30479739

Principle of rational prescribing and deprescribing in older adults with multiple chronic conditions.

Gregory M Ouellet1, Jennifer A Ouellet2, Mary E Tinetti2.   

Abstract

Although the majority of older adults in the developed world live with multiple chronic conditions (MCCs), the task of selecting optimal treatment regimens is still fraught with difficulty. Older adults with MCCs may derive less benefit from prescribed medications than healthier patients as a result of the competing risk of several possible outcomes including, but not limited to, death before a benefit can be accrued. In addition, these patients may be at increased risk of medication-related harms in the form of adverse effects and significant burdens of treatment. At present, the balance of these benefits and harms is often uncertain, given that older adults with MCCs are often excluded from clinical trials. In this review, we propose a framework to consider patients' own priorities to achieve optimal treatment regimens. To begin, the practicing clinician needs information on the patient's goals, what the patient is willing and able to do to achieve these goals, an estimate of the patient's clinical trajectory, and what the patient is actually taking. We then describe how to integrate this information to understand what matters most to the patient in the context of an array of potential tradeoffs. Finally, we propose conducting serial therapeutic trials of prescribing and deprescribing, with success measured as progress towards the patient's own health outcome goals. The process described in this manuscript is truly an iterative process, which should be repeated regularly to account for changes in the patient's priorities and clinical status. With this process, we aim to achieve optimal prescribing, that is, treatment regimens that maximize benefits that matter to the patient and minimize burdens and potential harms.

Entities:  

Keywords:  chronic conditions; deprescriptions; health priorities; medications; multimorbidity; polypharmacy; prescriptions

Year:  2018        PMID: 30479739      PMCID: PMC6243421          DOI: 10.1177/2042098618791371

Source DB:  PubMed          Journal:  Ther Adv Drug Saf        ISSN: 2042-0986


  82 in total

1.  Consideration of multiple chronic diseases in randomized controlled trials.

Authors:  Alejandro R Jadad; Matthew J To; Mohamed Emara; Jennifer Jones
Journal:  JAMA       Date:  2011-12-28       Impact factor: 56.272

2.  Defining the Scope of Prognosis: Primary Care Clinicians' Perspectives on Predicting the Future Health of Older Adults.

Authors:  John M Thomas; Terri R Fried
Journal:  J Pain Symptom Manage       Date:  2018-02-05       Impact factor: 3.612

3.  A 'SMART' way to determine treatment goals in pharmacotherapy education.

Authors:  Jelle Tichelaar; Sjoerd H Uil den; Ninja F Antonini; Michiel A van Agtmael; Theo P G M de Vries; Milan C Richir
Journal:  Br J Clin Pharmacol       Date:  2016-04-07       Impact factor: 4.335

4.  Effect of the PREPARE Website vs an Easy-to-Read Advance Directive on Advance Care Planning Documentation and Engagement Among Veterans: A Randomized Clinical Trial.

Authors:  Rebecca L Sudore; John Boscardin; Mariko A Feuz; Ryan D McMahan; Mary T Katen; Deborah E Barnes
Journal:  JAMA Intern Med       Date:  2017-08-01       Impact factor: 21.873

5.  Predicting Mortality up to 14 Years Among Community-Dwelling Adults Aged 65 and Older.

Authors:  Mara A Schonberg; Vicky Li; Edward R Marcantonio; Roger B Davis; Ellen P McCarthy
Journal:  J Am Geriatr Soc       Date:  2017-02-21       Impact factor: 5.562

6.  Goal-setting in clinical medicine.

Authors:  E H Bradley; S T Bogardus; M E Tinetti; S K Inouye
Journal:  Soc Sci Med       Date:  1999-07       Impact factor: 4.634

7.  Goal setting as a shared decision making strategy among clinicians and their older patients.

Authors:  Dena J Schulman-Green; Aanand D Naik; Elizabeth H Bradley; Ruth McCorkle; Sidney T Bogardus
Journal:  Patient Educ Couns       Date:  2006-01-06

8.  Health outcome priorities among competing cardiovascular, fall injury, and medication-related symptom outcomes.

Authors:  Mary E Tinetti; Gail J McAvay; Terri R Fried; Heather G Allore; Joanna C Salmon; Joanne M Foody; Luann Bianco; Sandra Ginter; Liana Fraenkel
Journal:  J Am Geriatr Soc       Date:  2008-07-24       Impact factor: 5.562

9.  Care patterns in Medicare and their implications for pay for performance.

Authors:  Hoangmai H Pham; Deborah Schrag; Ann S O'Malley; Beny Wu; Peter B Bach
Journal:  N Engl J Med       Date:  2007-03-15       Impact factor: 91.245

10.  Optimizing medication appropriateness in older adults: a randomized clinical interventional trial to decrease anticholinergic burden.

Authors:  Daniela C Moga; Erin L Abner; Dorinda N Rigsby; Lynne Eckmann; Mark Huffmyer; Richard R Murphy; Beth B Coy; Gregory A Jicha
Journal:  Alzheimers Res Ther       Date:  2017-05-23       Impact factor: 6.982

View more
  11 in total

1.  Patient-Reported Barriers and Facilitators to Deprescribing Cardiovascular Medications.

Authors:  Parag Goyal; Tatiana Requijo; Birgit Siceloff; Megan J Shen; Ruth Masterson Creber; Sarah N Hilmer; Ian M Kronish; Mark S Lachs; Monika M Safford
Journal:  Drugs Aging       Date:  2020-02       Impact factor: 3.923

2.  Advancing the Science of Deprescribing: A Novel Comprehensive Conceptual Framework.

Authors:  Amy Linsky; Walid F Gellad; Jeffrey A Linder; Mark W Friedberg
Journal:  J Am Geriatr Soc       Date:  2019-08-20       Impact factor: 5.562

Review 3.  Deprescribing medicines in older people living with multimorbidity and polypharmacy: the TAILOR evidence synthesis.

Authors:  Joanne Reeve; Michelle Maden; Ruaraidh Hill; Amadea Turk; Kamal Mahtani; Geoff Wong; Dan Lasserson; Janet Krska; Dee Mangin; Richard Byng; Emma Wallace; Ed Ranson
Journal:  Health Technol Assess       Date:  2022-07       Impact factor: 4.106

Review 4.  Multi-Morbidity and Polypharmacy in Older People: Challenges and Opportunities for Clinical Practice.

Authors:  Pritti Aggarwal; Stephen J Woolford; Harnish P Patel
Journal:  Geriatrics (Basel)       Date:  2020-10-28

5.  How many older adults receive drugs of questionable clinical benefit near the end of life? A cohort study.

Authors:  Lucas Morin; Jonas W Wastesson; Marie-Laure Laroche; Johan Fastbom; Kristina Johnell
Journal:  Palliat Med       Date:  2019-06-07       Impact factor: 4.762

6.  The Smart Aging Platform for Assessing Early Phases of Cognitive Impairment in Patients With Neurodegenerative Diseases.

Authors:  Sara Bottiroli; Sara Bernini; Elena Cavallini; Elena Sinforiani; Chiara Zucchella; Stefania Pazzi; Paolo Cristiani; Tomaso Vecchi; Daniela Tost; Giorgio Sandrini; Cristina Tassorelli
Journal:  Front Psychol       Date:  2021-03-15

7.  Patient Preferences for Discussing Life Expectancy: a Systematic Review.

Authors:  Emma Bjørk; Wade Thompson; Jesper Ryg; Ove Gaardboe; Trine Lembrecht Jørgensen; Carina Lundby
Journal:  J Gen Intern Med       Date:  2021-08-02       Impact factor: 6.473

8.  "At 80 I Know Myself": Embodied Learning and Older Adults' Experiences of Polypharmacy and Perceptions of Deprescribing.

Authors:  Alison Ross; James Gillett
Journal:  Gerontol Geriatr Med       Date:  2019-12-20

9.  Foreword to the first special collection: Addressing the invisible iatrogenic epidemic: the role of deprescribing in polypharmacy and inappropriate medication use.

Authors:  Dee Mangin; Doron Garfinkel
Journal:  Ther Adv Drug Saf       Date:  2019-10-21

10.  Health informatics interventions to minimize out-of-pocket medication costs for patients: what providers want.

Authors:  Karalyn A Kiessling; Bradley E Iott; Jessica A Pater; Tammy R Toscos; Shauna R Wagner; Laura M Gottlieb; Tiffany C Veinot
Journal:  JAMIA Open       Date:  2022-02-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.